Selected article for: "antigenic shift and deep sequencing"

Author: Barzon, Luisa; Lavezzo, Enrico; Militello, Valentina; Toppo, Stefano; Palù, Giorgio
Title: Applications of Next-Generation Sequencing Technologies to Diagnostic Virology
  • Document date: 2011_11_14
  • ID: 01nuj0lk_27
    Snippet: In the diagnostic setting, metagenomic approaches could be used for systematic analysis of samples collected from patients with unexplained illness, especially in the context of outbreaks and epidemics [70, 71] . As mentioned in the above section, application of high throughput NGS methods in viral metagenomics can greatly enhance the chances to identify viruses in clinical samples, including viruses that are too divergent from known viruses to b.....
    Document: In the diagnostic setting, metagenomic approaches could be used for systematic analysis of samples collected from patients with unexplained illness, especially in the context of outbreaks and epidemics [70, 71] . As mentioned in the above section, application of high throughput NGS methods in viral metagenomics can greatly enhance the chances to identify viruses in clinical samples, including viruses that are too divergent from known viruses to be detected by PCR or microarray techniques (reviewed in ref. [20] ). An attractive application of metagenomic approaches is the study of influenza, given the constant threat of antigenic drift and shift. Deep sequencing strategies can be used to monitor the emergence of mutations that confer virulence or resistance to antiviral drugs, to detect influenza viruses in clinical samples, and to identify viral quasispecies [22, 31, 32] . In addition, deep sequencing of clinical samples allows to identify and characterize not only novel pathogens but also the microbiota and host response to infection [32] .

    Search related documents:
    Co phrase search for related documents
    • antigenic drift and high throughput: 1
    • antigenic drift and influenza study: 1, 2, 3, 4, 5, 6
    • antigenic drift and influenza virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral drug and clinical sample: 1
    • antiviral drug and constant threat: 1, 2, 3, 4
    • antiviral drug and deep sequencing: 1, 2, 3
    • antiviral drug and epidemic outbreak: 1, 2, 3
    • antiviral drug and high throughput: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral drug and influenza study: 1, 2, 3, 4, 5, 6, 7
    • antiviral drug and influenza virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • attractive application and influenza virus: 1
    • clinical sample and deep sequencing: 1, 2, 3
    • clinical sample and diagnostic setting: 1
    • clinical sample and epidemic outbreak: 1
    • clinical sample and high throughput: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • clinical sample and influenza study: 1
    • clinical sample and influenza virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • constant threat and influenza virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • deep sequencing and influenza virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19